These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 20464561

  • 1. Novel photodynamic therapy against biliary tract carcinoma using mono-L: -aspartyl chlorine e6: basic evaluation for its feasibility and efficacy.
    Kasuya K, Shimazu M, Suzuki M, Kuroiwa Y, Usuda J, Itoi T, Tsuchida A, Aoki T.
    J Hepatobiliary Pancreat Sci; 2010 May; 17(3):313-21. PubMed ID: 20464561
    [Abstract] [Full Text] [Related]

  • 2. Expression of vascular endothelial growth factor by photodynamic therapy with mono-L-aspartyl chlorin e6 (NPe6) in oral squamous cell carcinoma.
    Nakagawa H, Matsumiya T, Sakaki H, Imaizumi T, Kubota K, Kusumi A, Kobayashi W, Kimura H.
    Oral Oncol; 2007 Jul; 43(6):544-50. PubMed ID: 17257889
    [Abstract] [Full Text] [Related]

  • 3. Photodynamic therapy using mono-L-aspartyl chlorin e6 (Npe6) for the treatment of cutaneous disease: a Phase I clinical study.
    Taber SW, Fingar VH, Coots CT, Wieman TJ.
    Clin Cancer Res; 1998 Nov; 4(11):2741-6. PubMed ID: 9829737
    [Abstract] [Full Text] [Related]

  • 4. Killing tumor cells: the effect of photodynamic therapy using mono-L-aspartyl chlorine and NS-398.
    Harvey EH, Webber J, Kessel D, Fromm D.
    Am J Surg; 2005 Mar; 189(3):302-5. PubMed ID: 15792755
    [Abstract] [Full Text] [Related]

  • 5. Photodynamic therapy with mono-L-aspartyl chlorin e6 can cause necrosis of squamous cell carcinoma of tongue: experimental study on an animal model of nude mouse.
    Kobayashi W, Liu Q, Nakagawa H, Sakaki H, Teh B, Matsumiya T, Yoshida H, Imaizumi T, Satoh K, Kimura H.
    Oral Oncol; 2006 Jan; 42(1):46-50. PubMed ID: 16266818
    [Abstract] [Full Text] [Related]

  • 6. Endovascular photodynamic therapy using mono-L-aspartyl-chlorin e6 to inhibit Intimal hyperplasia in balloon-injured rabbit arteries.
    Nagae T, Aizawa K, Uchimura N, Tani D, Abe M, Fujishima K, Wilson SE, Ishimaru S.
    Lasers Surg Med; 2001 Jan; 28(4):381-8. PubMed ID: 11344521
    [Abstract] [Full Text] [Related]

  • 7. Morphologic evaluation of the antitumor activity of photodynamic therapy (PDT) using mono-L-aspartyl chlorin e6 (NPe6) against uterine cervical carcinoma cell lines.
    Nakamura H, Suzuki Y, Takeichi M, Saito T, Takayama M, Aizawa K.
    Int J Gynecol Cancer; 2002 Jan; 12(2):177-86. PubMed ID: 11975677
    [Abstract] [Full Text] [Related]

  • 8. Photodynamic therapy of intestinal tumors with mono-L-aspartyl chlorin e6 (NPe6): a basic study.
    Kikuchi T, Asakura T, Aihara H, Shiraki M, Takagi S, Kinouchi Y, Aizawa K, Shimosegawa T.
    Anticancer Res; 2003 Jan; 23(6C):4897-900. PubMed ID: 14981942
    [Abstract] [Full Text] [Related]

  • 9. Mono-L-aspartyl chlorin e6 (NPe6) and hematoporphyrin derivative (HpD) in photodynamic therapy administered to a human cholangiocarcinoma model.
    Wong Kee Song LM, Wang KK, Zinsmeister AR.
    Cancer; 1998 Jan 15; 82(2):421-7. PubMed ID: 9445202
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetics and clinical effects of mono-L-aspartyl chlorin e6 (NPe6) photodynamic therapy in adult patients with primary or secondary cancer of the skin and mucosal surfaces.
    Chan AL, Juarez M, Allen R, Volz W, Albertson T.
    Photodermatol Photoimmunol Photomed; 2005 Apr 15; 21(2):72-8. PubMed ID: 15752124
    [Abstract] [Full Text] [Related]

  • 11. [Potential of photodynamic therapy with a second-generation sensitizer: mono-L-aspartyl chlorin e6].
    Mori K, Ohta M, Sano A, Yoneya S, Sonoda M, Kaneda A, Sato Y.
    Nippon Ganka Gakkai Zasshi; 1997 Feb 15; 101(2):134-40. PubMed ID: 9124093
    [Abstract] [Full Text] [Related]

  • 12. Low-level light therapy potentiates NPe6-mediated photodynamic therapy in a human osteosarcoma cell line via increased ATP.
    Tsai SR, Yin R, Huang YY, Sheu BC, Lee SC, Hamblin MR.
    Photodiagnosis Photodyn Ther; 2015 Mar 15; 12(1):123-30. PubMed ID: 25462575
    [Abstract] [Full Text] [Related]

  • 13. Photodynamic therapy using talaporfin sodium induces concentration-dependent programmed necroptosis in human glioblastoma T98G cells.
    Miki Y, Akimoto J, Moritake K, Hironaka C, Fujiwara Y.
    Lasers Med Sci; 2015 Aug 15; 30(6):1739-45. PubMed ID: 26109138
    [Abstract] [Full Text] [Related]

  • 14. Concomitant treatment with temozolomide enhances apoptotic cell death in glioma cells induced by photodynamic therapy with talaporfin sodium.
    Miki Y, Akimoto J, Omata H, Moritake K, Hiranuma M, Hironaka C, Fujiwara Y, Beppu M.
    Photodiagnosis Photodyn Ther; 2014 Dec 15; 11(4):556-64. PubMed ID: 25262961
    [Abstract] [Full Text] [Related]

  • 15. Phase II clinical study of photodynamic therapy using mono-L-aspartyl chlorin e6 and diode laser for early superficial squamous cell carcinoma of the lung.
    Kato H, Furukawa K, Sato M, Okunaka T, Kusunoki Y, Kawahara M, Fukuoka M, Miyazawa T, Yana T, Matsui K, Shiraishi T, Horinouchi H.
    Lung Cancer; 2003 Oct 15; 42(1):103-11. PubMed ID: 14512194
    [Abstract] [Full Text] [Related]

  • 16. Outcome of photodynamic therapy using NPe6 for bronchogenic carcinomas in central airways >1.0 cm in diameter.
    Usuda J, Ichinose S, Ishizumi T, Hayashi H, Ohtani K, Maehara S, Ono S, Honda H, Kajiwara N, Uchida O, Tsutsui H, Ohira T, Kato H, Ikeda N.
    Clin Cancer Res; 2010 Apr 01; 16(7):2198-204. PubMed ID: 20332318
    [Abstract] [Full Text] [Related]

  • 17. Effects of photodynamic therapy using a fractionated dosing of mono-L-aspartyl chlorin e6 in a murine tumor.
    Webber J, Leeson B, Fromm D, Kessel D.
    J Photochem Photobiol B; 2005 Feb 01; 78(2):135-40. PubMed ID: 15664500
    [Abstract] [Full Text] [Related]

  • 18. Tissue distribution and photosensitizing properties of mono-L-aspartyl chlorin e6 in a mouse tumor model.
    Gomer CJ, Ferrario A.
    Cancer Res; 1990 Jul 01; 50(13):3985-90. PubMed ID: 2354446
    [Abstract] [Full Text] [Related]

  • 19. High expression of GADD-45alpha and VEGF induced tumor recurrence via upregulation of IL-2 after photodynamic therapy using NPe6.
    Ohtani K, Usuda J, Ichinose S, Ishizumi T, Hirata T, Inoue T, Maehara S, Imai K, Kubota M, Tsunoda Y, Yamada M, Tsutsui H, Yamada K, Kuroiwa Y, Furukawa K, Okunaka T, Kato H.
    Int J Oncol; 2008 Feb 01; 32(2):397-403. PubMed ID: 18202762
    [Abstract] [Full Text] [Related]

  • 20. Photodynamic therapy in combination with talaporfin sodium induces mitochondrial apoptotic cell death accompanied with necrosis in glioma cells.
    Miki Y, Akimoto J, Yokoyama S, Homma T, Tsutsumi M, Haraoka J, Hirano K, Beppu M.
    Biol Pharm Bull; 2013 Feb 01; 36(2):215-21. PubMed ID: 23196427
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.